https://www.marketscreener.com/quote/stock/CYTOKINETICS-INCORPORATED-13479846/news/Cytokinetics-Announces-Dosing-of-First-Patient-in-Japan-in-GALACTIC-HF-Phase-3-Clinical-Trial-of-Om-25140088/?utm_source=telegram&utm_medium=social&utm_campaign=share